Schedule 13G ownership disclosure
EDWARDS LIFESCIENCES CORP COM
Common Stock · CUSIP: 28176E108
Event date: 2024-12-31
- Filing-level shares
- 69,131,602
- Percent of class
- 11.72%
- The Vanguard Group
Shares: 69,131,602 · Class: 11.72%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000120
- Form type
- SCHEDULE 13G/A
- Filer
- Edwards Lifesciences Corp
- CIK
- CIK 1099800
- Filed
- Jan 30, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership